Vistagen Therapeutics has reported positive Phase 3 trial results for a social anxiety treatment. VTGN stock is skyrocketing as a result. More
Articles
PLUG’s Earnings Alarm: Why It’s Not the Hydrogen Stock to Bank On.
Even if you have high hopes for the hydrogen industry, you'll still want to be wary of PLUG stock as Plug Power's financials aren't ideal. More
Dear RIVN Stock Fans, Mark Your Calendars for Aug. 8
Shareholders of RIVN stock will want to keep an eye out, as Rivian will report its second-quarter earnings tomorrow after the market close. More
Dear AAPL Stock Fans, Mark Your Calendars for Sept. 22
While anticipation runs hot for Apple’s next-gen iPhone 15, rising economic pressures put a harsh spotlight on AAPL stock. More